Literature DB >> 343583

Acute digoxin poisonings: review of therapy.

B R Ekins, A S Watanabe.   

Abstract

Acute digoxin poisoning, its recognition and management, are reviewed. The uses of syrup of ipecac, gastric lavage, activated charcoal, cholestyramine, colestipol, edetate sodium and cathartics as measures to terminate the drug exposure are discussed. Measures to hasten digoxin elimination, such as the use of furosemide, hemodialysis and digoxin-specific antibodies are reviewed. Supportive management may include treatment with atropine, phenytoin, lidocaine, propranolol, glucose, insulin and sodium polystyrene sulfonate. Proper management of digoxin poisoning involves the use of standard decontamination procedures (emesis or gastric lavage). Activated charcoal is strongly recommended, followed by rapidly acting cathartics. Antiarrhythmic therapy usually involves atropine sulfate and phenytoin sodium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343583

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  6 in total

1.  Economic impact of digoxin toxicity.

Authors:  A J Gandhi; P H Vlasses; D J Morton; J L Bauman
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

2.  Suicidal digoxin poisoning: conventional treatment and antibody therapy.

Authors:  T Hess; H U Dubach; G Scholtysik; W Riesen
Journal:  Klin Wochenschr       Date:  1982-04-15

Review 3.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

4.  Inadequate information about drug overdosage in manufacturers' data sheets.

Authors:  R N Illingworth; L F Prescott
Journal:  Br Med J       Date:  1980-06-14

5.  Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake.

Authors:  T E Bunchman; E G Wood; M H Schenck; K A Weaver; B L Klein; R E Lynch
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Poisoning by Plants.

Authors:  Sebastian Wendt; Christoph Lübbert; Kathrin Begemann; Dagmar Prasa; Heike Franke
Journal:  Dtsch Arztebl Int       Date:  2022-05-06       Impact factor: 8.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.